SMPDB ID,Pathway Name,Pathway Subject,Metabolite ID,Metabolite Name,HMDB ID,KEGG ID,ChEBI ID,DrugBank ID,CAS,Formula,IUPAC,SMILES,InChI,InChI Key
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000414,Adenosine triphosphate,HMDB0000538,C00002,15422,DB00171,56-65-5,C10H16N5O13P3,"({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",ZKHQWZAMYRWXGA-KQYNXXCUSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000105,L-Alanine,HMDB0000161,C00041,16977,DB00160,56-41-7,C3H7NO2,(2S)-2-aminopropanoic acid,C[C@H](N)C(O)=O,"InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1",QNAYBMKLOCPYGJ-REOHCLBHSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000032,Adenosine monophosphate,HMDB0000045,C00020,16027,DB00131,61-19-8,C10H14N5O7P,"{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid",NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",UDMBCSSLTHHNCD-KQYNXXCUSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000170,Pyrophosphate,HMDB0000250,C00013,18361,DB04160,14000-31-8,O7P2,(phosphonooxy)phosphonate,[O-]P([O-])(=O)OP([O-])([O-])=O,"InChI=1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-4",XPPKVPWEQAFLFU-UHFFFAOYSA-J
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C001005,Zinc (II) ion,HMDB0001303,C00038,29105,DB01593,23713-49-7,Zn,zinc(2+) ion,[Zn++],InChI=1S/Zn/q+2,PTFCDOFLOPIGGS-UHFFFAOYSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000134,Oxoglutaric acid,HMDB0000208,C00026,30915,DB02926,328-50-7,C5H6O5,2-oxopentanedioic acid,OC(=O)CCC(=O)C(O)=O,"InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)",KPGXRSRHYNQIFN-UHFFFAOYSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000095,L-Glutamic acid,HMDB0000148,C00025,16015,DB00142,56-86-0,C5H9NO4,(2S)-2-aminopentanedioic acid,N[C@@H](CCC(O)=O)C(O)=O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",WHUUTDBJXJRKMK-VKHMYHEASA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000164,Pyruvic acid,HMDB0000243,C00022,32816,DB00119,127-17-3,C3H4O3,2-oxopropanoic acid,CC(=O)C(O)=O,"InChI=1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6)",LCTONWCANYUPML-UHFFFAOYSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C001148,Pyridoxal 5'-phosphate,HMDB0001491,C00018,18405,DB00114,54-47-7,C8H10NO6P,[(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methoxy]phosphonic acid,CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O,"InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14)",NGVDGCNFYWLIFO-UHFFFAOYSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000463,Hydrogen carbonate,HMDB0000595,C00288,17544,,71-52-3,CHO3,hydrogen carbonate,OC([O-])=O,"InChI=1S/CH2O3/c2-1(3)4/h(H2,2,3,4)/p-1",BVKZGUZCCUSVTD-UHFFFAOYSA-M
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C001034,Adenosine diphosphate,HMDB0001341,C00008,16761,,58-64-0,C10H15N5O10P2,"[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid",NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",XTWYTFMLZFPYCI-KQYNXXCUSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C001104,Phosphate,HMDB0001429,C00009,18367,"",14265-44-2,O4P,phosphate,[O-]P([O-])([O-])=O,"InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)/p-3",NBIIXXVUZAFLBC-UHFFFAOYSA-K
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000148,Oxalacetic acid,HMDB0000223,C00036,30744,,328-42-7,C4H4O5,2-oxobutanedioic acid,OC(=O)CC(=O)C(O)=O,"InChI=1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9)",KHPXUQMNIQBQEV-UHFFFAOYSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000020,Biotin,HMDB0000030,C00120,15956,DB00121,58-85-5,C10H16N2O3S,"5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanoic acid",[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,"InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1",YBJHBAHKTGYVGT-ZKWXMUAHSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C001027,Manganese,HMDB0001333,C19610,29035,,16397-91-4,Mn,manganese(2+) ion,[Mn++],InChI=1S/Mn/q+2,WAEMQWOKJMHJLA-UHFFFAOYSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000075,Glyoxylic acid,HMDB0000119,C00048,16891,DB04343,298-12-4,C2H2O3,2-oxoacetic acid,OC(=O)C=O,"InChI=1S/C2H2O3/c3-1-2(4)5/h1H,(H,4,5)",HHLFWLYXYJOTON-UHFFFAOYSA-N
SMP0000352,Primary Hyperoxaluria Type I,Disease,PW_C000078,Glycine,HMDB0000123,C00037,15428,DB00145,56-40-6,C2H5NO2,2-aminoacetic acid,NCC(O)=O,"InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)",DHMQDGOQFOQNFH-UHFFFAOYSA-N
